Literature DB >> 18336857

Conservation of fiber structure and CD46 usage by subgroup B2 adenoviruses.

Lars Pache1, Sangita Venkataraman, Glen R Nemerow, Vijay S Reddy.   

Abstract

Most subgroup B2 adenoviruses use CD46 as their primary receptor. Recent structural and mutagenesis studies suggested that Ad11 and Ad35 likely engage this receptor in a very similar fashion. However, no comparative studies assessing the cell-associated CD46 binding efficiencies of different Ad fibers have been performed. We solved the crystal structure of Ad35 fiber knob and constructed a model of the fiber knob complexed with CD46. Comparison of our model with that of Ad11-CD46 showed that despite a larger CD46-interacting region in the IJ loop of Ad11, the buried surface area was very similar, suggesting that both fiber knobs might exhibit similar binding. In support of this, cell based competition studies demonstrated almost identical binding efficiencies of Ad11 and Ad35 fibers to cell surface CD46. These findings shed further light on CD46 association by Ad and could impact the selection of novel Ad types for gene transfer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18336857     DOI: 10.1016/j.virol.2008.02.013

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  14 in total

1.  Structural variations in species B adenovirus fibers impact CD46 association.

Authors:  Lars Pache; Sangita Venkataraman; Vijay S Reddy; Glen R Nemerow
Journal:  J Virol       Date:  2008-06-04       Impact factor: 5.103

2.  Structure of adenovirus type 21 knob in complex with CD46 reveals key differences in receptor contacts among species B adenoviruses.

Authors:  Karolina Cupelli; Steffen Müller; B David Persson; Marco Jost; Niklas Arnberg; Thilo Stehle
Journal:  J Virol       Date:  2010-01-13       Impact factor: 5.103

Review 3.  Adenovirus.

Authors:  Jason G Smith; Christopher M Wiethoff; Phoebe L Stewart; Glen R Nemerow
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

4.  Avidity binding of human adenovirus serotypes 3 and 7 to the membrane cofactor CD46 triggers infection.

Authors:  Hung V Trinh; Guillaume Lesage; Venus Chennamparampil; Benedikt Vollenweider; Christoph J Burckhardt; Stefan Schauer; Menzo Havenga; Urs F Greber; Silvio Hemmi
Journal:  J Virol       Date:  2011-11-30       Impact factor: 5.103

5.  Adenovirus type-35 vectors block human CD4+ T-cell activation via CD46 ligation.

Authors:  William C Adams; Cornelia Gujer; Gerald McInerney; Jason G D Gall; Constantinos Petrovas; Gunilla B Karlsson Hedestam; Richard A Koup; Karin Loré
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-18       Impact factor: 11.205

6.  Conserved fiber-penton base interaction revealed by nearly atomic resolution cryo-electron microscopy of the structure of adenovirus provides insight into receptor interaction.

Authors:  Changchun Cao; Xiaoyan Dong; Xiaobing Wu; Boyun Wen; Gang Ji; Lingpeng Cheng; Hongrong Liu
Journal:  J Virol       Date:  2012-09-05       Impact factor: 5.103

7.  Selection Pressure in the Human Adenovirus Fiber Knob Drives Cell Specificity in Epidemic Keratoconjunctivitis.

Authors:  Ashrafali M Ismail; Ji Sun Lee; David W Dyer; Donald Seto; Jaya Rajaiya; James Chodosh
Journal:  J Virol       Date:  2016-10-14       Impact factor: 5.103

8.  Structural and functional studies on the interaction of adenovirus fiber knobs and desmoglein 2.

Authors:  Hongjie Wang; Roma Yumul; Hua Cao; Liang Ran; Xiaolong Fan; Maximilian Richter; Forrest Epstein; Julie Gralow; Chloe Zubieta; Pascal Fender; André Lieber
Journal:  J Virol       Date:  2013-08-14       Impact factor: 5.103

Review 9.  Latest insights on adenovirus structure and assembly.

Authors:  Carmen San Martín
Journal:  Viruses       Date:  2012-05-21       Impact factor: 5.048

Review 10.  Adenovirus receptors and their implications in gene delivery.

Authors:  Anurag Sharma; Xiaoxin Li; Dinesh S Bangari; Suresh K Mittal
Journal:  Virus Res       Date:  2009-02-26       Impact factor: 3.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.